Pfizer Inc
Change company Symbol lookup
Select an option...
PFE Pfizer Inc
HSTRF Hollister Biosciences Inc
T AT&T Inc
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
MSFT Microsoft Corp
PEY Invesco High Yield Equity Dividend Achievers™ ETF
BAC Bank of America Corp
ARI Apollo Commercial Real Estate Finance Inc
ISNPY Intesa Sanpaolo SpA
BRKR Bruker Corp
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Closing Price
$36.55
Day's Change
0.07 (0.19%)
Bid
--
Ask
--
B/A Size
--
Day's High
36.83
Day's Low
36.25
Volume
(Light)
Volume:
26,271,163

10-day average volume:
34,663,858
26,271,163
Latest Earnings Met Consensus (Q3 ending 09/2020)Next Earnings Announcement
Q3
Announced October 27, 2020
$0.72Q3 Estimate range
of 13 analysts
$0.60 to $0.79Q4 Earnings
will announce
(Unconfirmed) February 2, 2021

Quarterly Earnings History and Estimates

Hide high-low estimates
Draw trendlines

Draw up to 3 lines inside the chart.

Display:

UpdateCancel

PFE's fiscal year ends in December

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Information provided by Copyright © 2021. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.